NYSEARCA:PSIL AdvisorShares Psychedelics ETF (PSIL) Price, Holdings, & News → America’s worst nightmare? (From Porter & Company) (Ad) Free PSIL Stock Alerts $1.22 -0.03 (-2.40%) (As of 05/14/2024 ET) Add Compare Share Share Today's Range$1.21▼$1.2450-Day Range$1.21▼$1.6952-Week Range$1.20▼$2.25Volume131,796 shsAverage Volume70,244 shsMarket Capitalization$6.86 millionAssets Under Management$6.77 millionDividend Yield4.10%Net Expense Ratio1.00% Stock AnalysisStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings Get AdvisorShares Psychedelics ETF alerts: Email Address About AdvisorShares Psychedelics ETF (NYSEARCA:PSIL)The AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to the emerging global psychedelics industry. PSIL was launched on Sep 15, 2021 and is managed by AdvisorShares.Read More PSIL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PSIL ETF News HeadlinesFebruary 13, 2024 | thestreet.comAdvisorShares Psychedelics ETFDecember 18, 2023 | markets.businessinsider.comPsyched: Biden's Big Decision On Psychedelics Therapy; LSD Anxiety Results; Matthew Perry Autopsy And MoreSeptember 11, 2023 | markets.businessinsider.comPsyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And MoreAugust 21, 2023 | benzinga.comPsyched: Fed Study On Psychedelics, Janet Yellen's Magic Mushrooms, Financing Deals & Quarterly ReportsJuly 24, 2023 | benzinga.comPsyched: Germany Ships LSD Prodrugs Via DHL, Minneapolis Decriminalizes, Wiz Khalifa's Magic Pitch & MoreJuly 15, 2023 | msn.comWatch these psychedelic stocks as sector faces year of 'collapse and consolidation'July 11, 2023 | markets.businessinsider.comPsyched: Australia's Innovative Program, Congressional Amendments, Therapy Reimbursement And MoreMay 15, 2023 | markets.businessinsider.comPsyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & MoreSee More Headlines Receive PSIL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AdvisorShares Psychedelics ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerAdvisorShares Fund NameAdvisorShares Psychedelics ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:PSIL Inception Date9/15/2021 Fund ManagerDan S. Ahrens WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings28 Fund Statistics Assets Under Management$6.77 million Average Daily Volume$0.00 Discount/Premium0.05% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorAdvisorShares Investments, LLC CustodianThe Bank of New York Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume21 Put Options210 Call Options21 Miscellaneous Outstanding Shares5,620,000Beta0.82 Creation Fee$500.00 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Ad Chaikin AnalyticsMy system predicted the BA collapse – now it’s issuing an AI warningEven after several plane crashes and equipment malfunctions... a congressional hearing... and the worst PR firestorm in recent memory... The FTC's commission chair Lina Khan still deems Boeing (BA), "too big to fail" Click to see why a similar situation is currently brewing in the AI market... AdvisorShares Psychedelics ETF ExpensesTypePSILTheme ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.60%0.57%0.54%0.50%0.51%Other Expenses2.51%0.72%0.54%0.64%0.58%Total Expense3.11%0.72%0.70%0.74%0.70%Fee Waiver-2.11%-0.76%-0.55%-0.68%-0.57%Net Expense1.00%0.59%0.60%0.58%0.58% AdvisorShares Psychedelics ETF (PSIL) Holdings & ExposureTop 10 PSIL HoldingsMind Medicine (MindMed)(NASDAQ:MNMD)Holding Weight: 14.76%Cybin Inc Ordinary SharesHolding Weight: 9.30%COMPASS Pathways(NASDAQ:CMPS)Holding Weight: 6.93%Atai Life Sciences(NASDAQ:ATAI)Holding Weight: 5.43%Vistagen Therapeutics(NASDAQ:VTGN)Holding Weight: 5.42%GH Research(NASDAQ:GHRS)Holding Weight: 5.32%Intra-Cellular Therapies(NASDAQ:ITCI)Holding Weight: 5.28%BlackRock Liquidity Treasury InstlHolding Weight: 4.80%NRx Pharmaceuticals(NASDAQ:NRXP)Holding Weight: 4.75%Alkermes(NASDAQ:ALKS)Holding Weight: 4.73%PSIL Sector ExposurePSIL Industry ExposureFull Holdings Details Similar ETFsMast Global Battery Recycling & Production ETFNYSEARCA:EVIQ Engender Equality ETFNYSEARCA:EQULOptica Rare Earths & Critical Materials ETFNYSEARCA:CRITU.S. Global Sea to Sky Cargo ETFNYSEARCA:SEAProShares Big Data Refiners ETFNYSEARCA:DATInstitutional OwnershipSpire Wealth ManagementBought 18,000 shares on 4/24/2024Ownership: 0.773%View All Institutional Transactions PSIL ETF - Frequently Asked Questions How have PSIL shares performed in 2024? AdvisorShares Psychedelics ETF's stock was trading at $1.39 at the start of the year. Since then, PSIL shares have decreased by 12.2% and is now trading at $1.22. View the best growth stocks for 2024 here. What does PSIL invest in? AdvisorShares Psychedelics ETF is a equity fund issued by AdvisorShares. PSIL focuses on theme investments. The fund's investments total to approximately $6.77 million assets under management. What stocks does AdvisorShares Psychedelics ETF hold? PSIL invests in 28 holdings. Some of the stocks in their portfolio include Mind Medicine (MindMed) (MNMD), COMPASS Pathways (CMPS), Atai Life Sciences (ATAI), Vistagen Therapeutics (VTGN), GH Research (GHRS), Intra-Cellular Therapies (ITCI), NRx Pharmaceuticals (NRXP), Alkermes (ALKS), Relmada Therapeutics (RLMD) and Enveric Biosciences (ENVB). What is the management fee for AdvisorShares Psychedelics ETF? AdvisorShares Psychedelics ETF's management fee is 0.60% and has other expenses of 2.51%. However, PSIL has a fee waiver of -2.11% to reimburse the expenses. The net expense ratio for PSIL is 1.00%. Who are AdvisorShares Psychedelics ETF's major shareholders? AdvisorShares Psychedelics ETF's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Spire Wealth Management (0.77%). How do I buy shares of AdvisorShares Psychedelics ETF? Shares of PSIL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:PSIL) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe Crypto 9-5 Escape PlanCrypto 101 MediaThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersCharles Payne Demystifies OptionsUnstoppable ProsperityCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AdvisorShares Psychedelics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
